Sophia Genetics SA at Barclays Global Healthcare Conference Transcript
All right. Good afternoon, everybody. Luke Sergott, I cover life sciences tools and diagnostics here at Barclays. I have with me Jurgi, CEO of SOPHiA GENETICS. Thank you again for making. We're just talking to you -- your third time or at least being interviewed by me, second time at Barclays. So I guess what we can start here is, if you want to take a couple of minutes and go to the overview of the business and really what I want you to think about is how the business has changed over the last 12 to 18 months since you were here last time. And really the trajectory that you guys have going over for the next 2 to 3 years and the groundwork that you've laid and really kind of how you're expecting that to really flow through.
Sure. So it's a good question. And as you know, we went public in July 2021, right? And back then, there were kind of some questions about SOPHiA as well. And I think we've been able to answer to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
